Research & Development

偷拍自怕亚洲在线欧美无码中文字幕在线播放2热最新精品久久re在线Gartner报告:AWS市场份额下跌4% 阿里云增长近一倍

發布時間︰

  真正可謂牽一發而動全身。   阿嬌笑道︰“應有之事,何足掛齒,這孩子出生,是我的福報,非是我的冤孽。”偷拍自怕亚洲在线欧美   或許曹家,霍家,李家,謝家都應該去看看,同僚嘛,這點情義方便還是要給的。无码中文字幕在线播放2 第九十九章 青樓與學堂   婦人大哭,且聲嘶力竭……热最新精品久久re在线   霍去病對這些噪音充耳不聞,眼楮盯著戰場上早就設立好的界標,只要最後一隊羌人的腳步踏過界標,就該是射聲營發威的時候。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo